Chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of both sexes, under follow-up at Serviço de Pneumologia do HUPE, diagnosed with COPD based on the criteria established by GOLD; patients with stable disease; with Forced Expiratory Volume in the 1st Second less than 50%; independent patients; signed by the Free and Informed Consent Form.
Exclusion criteria
Exclusion criteria: Patients with exacerbation for less than 3 months; patients with labyrinthitis; patients with osteoporosis reported; patients with other respiratory diseases; patients using pacemaker; patients with previous history of fractures or other orthopedic diseases submitted to surgeries with implantation of metallic material; patients with peripheral vascular disease or thromboembolism; patients smoker or severe alcoholic; patients with decompensated cardiovascular disease; patients with aneurysm; patients with previous vitreous hemorrhage; patients in malnutrition; postoperative patients; patients with neurological disease that causes "fear" of movements on the vibrating platform; severe or incapacitating clinical illness, at the discretion of the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effects of WBVE on the electromyographic tracing of the vastus lateralis, vastus medialis and rectus femoris, through surface electromyography in individuals with COPD;To evaluate the effects of WBVE on blood pressure, heart rate, respiratory rate and oxygen saturation through pulse oximetry in individuals with COPD;To evaluate the effects of WBVE on dyspnea, through the Modified Scale of BORG and Medical Research Council (MRC) in individuals with COPD | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the effects of WBVE on flexibility, through the anterior trunk flexion (ATF) test in individuals with COPD;To evaluate the effects of WBVE on palmar grip strength through dynamometry in individuals with COPD;To evaluate the effects of WBVE on gait, balance and functional/lower limb strength through the Short Physical Performance Battery (SPPB) in individuals with COPD;To evaluate the effects of WBVE on fatigue through the BORG Scale, and on the effort through the Subjective Effort Perception Scale in individuals with COPD;To evaluate the effects of WBVE on quality of life using the St. Georges Respiratory Questionnaire (SGRQ) in individuals with COPD;To evaluate the effects of WBVE on the impact of COPD symptoms through the COPD assessment test (CAT) in individuals with COPD;To evaluate the effects of WBVE on biochemical blood markers, by means of blood sample collection in individuals with COPD;To evaluate the effects of WBVE on body composition through bioimpedance analysis in individuals with COPD;To assess the effects of WBVE on the composition Evaluate the effects of VCT on maximal inspiratory pressure and maximal expiratory pressure through manovacuometry in individuals with COPD | — |
Countries
Brazil
Contacts
Universidade do Estado do Rio de Janeiro